title: Age-dependent impairment of spine morphology and synaptic plasticity in hippocampal CA1 neurons of a presenilin 1 transgenic mouse model of Alzheimer's disease.
abstract: Presenilin 1 (PS1) mutations are responsible for a majority of early onset familial Alzheimer's disease (FAD) cases, in part by increasing the production of Abeta peptides. However, emerging evidence suggests other possible effects of PS1 on synaptic dysfunction where PS1 might contribute to the pathology independent of Abeta. We chose to study the L286V mutation, an aggressive FAD mutation which has never been analyzed at the electrophysiological and morphological levels. In addition, we analyzed for the first time the long term effects of wild-type human PS1 overexpression. We investigated the consequences of the overexpression of either wild-type human PS1 (hPS1) or the L286V mutated PS1 variant (mutPS1) on synaptic functions by analyzing synaptic plasticity and associated spine density changes from 3 to 15 months of age. We found that mutPS1 induces a transient increase observed only in 4- to 5-month-old mutPS1 animals in NMDA receptor (NMDA-R)-mediated responses and LTP compared with hPS1 mice and nontransgenic littermates. The increase in synaptic functions is concomitant with an increase in spine density. With increasing age, however, we found that the overexpression of human wild-type PS1 progressively decreased NMDA-R-mediated synaptic transmission and LTP, without neurodegeneration. These results identify for the first time a transient increase in synaptic function associated with L286V mutated PS1 variant in an age-dependent manner. In addition, they support the view that the PS1 overexpression promotes synaptic dysfunction in an Abeta-independent manner and underline the crucial role of PS1 during both normal and pathological aging.
authors.affiliation: Université Pierre et Marie Curie-Paris, Centre National de la Recherche Scientifique, France. alexandraauffret@gmail.com
authors.forename: Alexandra
authors.initials: A
authors.lastname: Auffret
authors.forename: Vanessa
authors.initials: V
authors.lastname: Gautheron
authors.forename: Mariaelena
authors.initials: M
authors.lastname: Repici
authors.forename: Rudolf
authors.initials: R
authors.lastname: Kraftsik
authors.forename: Howard T J
authors.initials: HT
authors.lastname: Mount
authors.forename: Jean
authors.initials: J
authors.lastname: Mariani
authors.forename: Catherine
authors.initials: C
authors.lastname: Rovira
mesh_terms: D000375:Aging; D000544:Alzheimer Disease / Q000235:genetics; D000818:Animals; D016923:Cell Death; D049229:Dendritic Spines / Q000235:genetics / Q000502:physiology*; D004195:Disease Models, Animal; D006624:Hippocampus / Q000166:cytology / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D017774:Long-Term Potentiation / Q000235:genetics / Q000502:physiology; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D020125:Mutation, Missense; D009473:Neuronal Plasticity / Q000235:genetics / Q000502:physiology*; D009474:Neurons / Q000166:cytology / Q000502:physiology*; D053764:Presenilin-1 / Q000235:genetics / Q000378:metabolism*; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism; D013569:Synapses / Q000235:genetics / Q000502:physiology; D009435:Synaptic Transmission / Q000235:genetics / Q000502:physiology
chemical_list: D053764:Presenilin-1; D016194:Receptors, N-Methyl-D-Aspartate
references.citation: Nature. 1999 Nov 25;402(6760):421-5
references.pmid: 10586883
references.citation: Neurobiol Dis. 1999 Feb;6(1):56-62
references.pmid: 10078973
references.citation: Science. 1999 Mar 19;283(5409):1923-7
references.pmid: 10082466
references.citation: J Neurosci. 2007 Oct 31;27(44):11832-7
references.pmid: 17978019
references.citation: Hippocampus. 2004;14(2):255-64
references.pmid: 15098730
references.citation: Cell. 2006 Sep 8;126(5):981-93
references.pmid: 16959576
references.citation: Pharmacol Res. 2004 Oct;50(4):411-8
references.pmid: 15304238
references.citation: Nature. 1995 Jun 29;375(6534):754-60
references.pmid: 7596406
references.citation: J Neurosci. 2008 Dec 31;28(53):14537-45
references.pmid: 19118188
references.citation: Diabetes. 2001 Jan;50(1):77-82
references.pmid: 11147798
references.citation: Nature. 2000 Apr 20;404(6780):876-81
references.pmid: 10786794
references.citation: Nature. 1999 May 6;399(6731):66-70
references.pmid: 10331391
references.citation: Mol Neurodegener. 2006 Jun 12;1:4
references.pmid: 16930451
references.citation: Science. 2002 Oct 25;298(5594):789-91
references.pmid: 12399581
references.citation: J Biol Chem. 2007 Jan 12;282(2):1119-27
references.pmid: 17088253
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5161-6
references.pmid: 16549764
references.citation: J Neurosci. 2008 May 28;28(22):5740-51
references.pmid: 18509035
references.citation: Neuron. 2004 Apr 8;42(1):23-36
references.pmid: 15066262
references.citation: Anat Rec. 1999 Aug 15;257(4):119-20
references.pmid: 10467241
references.citation: J Neurosci Methods. 1995 Jun;59(1):151-6
references.pmid: 7475245
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3410-5
references.pmid: 16492745
references.citation: J Exp Biol. 2009 Feb;212(Pt 4):494-8
references.pmid: 19181896
references.citation: Annu Rev Neurosci. 2007;30:79-97
references.pmid: 17280523
references.citation: Neurobiol Dis. 2000 Feb;7(1):54-63
references.pmid: 10671322
references.citation: J Neurosci. 2001 Jul 1;21(13):4691-8
references.pmid: 11425896
references.citation: Annu Rev Neurosci. 2001;24:1071-89
references.pmid: 11520928
references.citation: Nat Rev Neurosci. 2005 Apr;6(4):277-84
references.pmid: 15803159
references.citation: Nat Med. 1997 Jan;3(1):67-72
references.pmid: 8986743
references.citation: Annu Rev Physiol. 2002;64:355-405
references.pmid: 11826273
references.citation: J Neurosci. 2007 Jul 25;27(30):8149-56
references.pmid: 17652605
references.citation: Neurobiol Dis. 2000 Apr;7(2):119-26
references.pmid: 10783295
references.citation: Nat Neurosci. 2005 Aug;8(8):1051-8
references.pmid: 16025111
references.citation: Neurobiol Aging. 2009 Jul;30(7):1061-8
references.pmid: 18068871
references.citation: J Neurosci. 2008 Feb 6;28(6):1410-20
references.pmid: 18256261
references.citation: Neuron. 2003 Mar 27;37(6):925-37
references.pmid: 12670422
references.citation: Neurosci Lett. 1996 Apr 26;208(3):195-8
references.pmid: 8733303
references.citation: J Neurosci. 2007 Mar 14;27(11):2866-75
references.pmid: 17360908
references.citation: J Neurosci Methods. 1998 Jan 31;79(1):1-4
references.pmid: 9531453
references.citation: Nat Rev Neurosci. 2002 Nov;3(11):862-72
references.pmid: 12415294
references.citation: Annu Rev Physiol. 2002;64:313-53
references.pmid: 11826272
references.citation: Neurobiol Aging. 2008 May;29(5):639-52
references.pmid: 17222948
references.citation: J Clin Invest. 2007 May;117(5):1230-9
references.pmid: 17431506
references.citation: J Neurosci. 2004 Sep 8;24(36):7821-8
references.pmid: 15356193
references.citation: J Neurosci. 2007 Jan 24;27(4):796-807
references.pmid: 17251419
references.citation: Neurobiol Aging. 2000 Jul-Aug;21(4):541-9
references.pmid: 10924767